STOCK TITAN

Cardiff Lexingto (CDIXD) Form 4 Filings

CDIXD OTC

Here are the Form 4 insider transactions from Cardiff Lexingto (CDIXD) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow CDIXD and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CDIXD filings page.

Rhea-AI Summary

Staley Louis Jack Sr. reported acquisition or exercise transactions in this Form 4 filing.

Cardiff Lexington Corp director Staley Louis Jack Sr. received a grant of 5,000 shares of Common Stock as a restricted stock award on April 1, 2026. The award was granted at a price of $0.00 per share as equity compensation, not an open-market purchase. The shares are scheduled to vest in equal installments quarterly over four quarters starting July 1, 2026, contingent on his continued service under the company’s 2024 Equity Incentive Plan. Following this grant, he beneficially owns 11,668 shares of Common Stock directly.

Rhea-AI Summary

Cardiff Lexington Corp’s chief executive officer and director Alex H. Cunningham converted a large deferred pay balance into equity. On January 29, 2026, deferred compensation of $2,365,242 owed to him by the company was cancelled in exchange for 556,528 shares of common stock at $0 per share.

After this transaction, Cunningham directly beneficially owned 3,914,230 shares of common stock, and an additional 889,398 shares were held indirectly through the Alexander Hunt Cunningham, Sr. Revocable Trust.